Cogent Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 16.57 M | $129.24 M | 99.16% | 15.04% |
KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 9.11 M | $71.02 M | -1.46% | 8.26% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 8.34 M | $65.05 M | 4.35% | 7.57% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 6.96 M | $54.32 M | 0.00% | 6.32% |
COMMODORE CAPITAL LP | 02/14/2025 | 6.88 M | $53.68 M | -8.73% | 6.25% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 02/14/2025 | 6.23 M | $48.56 M | 0.00% | 5.65% |
VANGUARD GROUP INC | 02/11/2025 | 6.13 M | $47.84 M | 7.33% | 5.57% |
VR ADVISER, LLC | 02/14/2025 | 5.68 M | $44.34 M | 0.00% | 5.16% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 5.35 M | $41.71 M | -48.93% | 4.85% |
PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 4.92 M | $38.36 M | 6.67% | 4.46% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 4.30 M | $33.54 M | 5.75% | 3.90% |
STATE STREET CORP | 02/14/2025 | 3.92 M | $30.56 M | 21.25% | 3.56% |
REDMILE GROUP, LLC | 02/14/2025 | 3.55 M | $27.73 M | -20.73% | 3.23% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 2.76 M | $21.55 M | 111.72% | 2.51% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 2.63 M | $20.52 M | -29.73% | 2.39% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.31 M | $18.01 M | 1.22% | 2.10% |
SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.50 M | $11.69 M | -12.52% | 1.36% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.28 M | $10.01 M | 28.35% | 1.17% |
VIVO CAPITAL, LLC | 02/13/2025 | 1.12 M | $8.76 M | 0.00% | 1.02% |
WALLEYE CAPITAL LLC | 02/13/2025 | 936,791 | $7.31 M | 68.09% | 0.85% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 936,576 | $7.31 M | 0.00% | 0.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 921,137 | $7.18 M | -24.58% | 0.84% |
SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 910,865 | $7.10 M | 100.00% | 0.83% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 864,893 | $6.75 M | -1.50% | 0.79% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 852,855 | $6.65 M | 7.83% | 0.77% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 833,155 | $6.50 M | 0.89% | 0.76% |
SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 823,160 | $6.42 M | -63.66% | 0.75% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 743,652 | $5.80 M | -6.15% | 0.68% |
WOODLINE PARTNERS LP | 02/14/2025 | 613,165 | $4.78 M | 2.10% | 0.56% |
02/13/2025 | 548,554 | $4.28 M | 100.00% | 0.50% | |
READYSTATE ASSET MANAGEMENT LP | 02/14/2025 | 520,000 | $4.06 M | 100.00% | 0.47% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 473,693 | $3.69 M | -21.99% | 0.43% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 464,942 | $3.63 M | 466.59% | 0.42% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 457,048 | $3.56 M | -1.11% | 0.41% |
CRESTLINE MANAGEMENT, LP | 02/14/2025 | 369,763 | $2.88 M | 0.00% | 0.34% |
ALGERT GLOBAL LLC | 02/14/2025 | 344,235 | $2.69 M | 92.28% | 0.31% |
D. E. SHAW & CO., INC. | 02/14/2025 | 339,988 | $2.65 M | -25.64% | 0.31% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 313,099 | $2.44 M | -0.60% | 0.28% |
AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 287,104 | $2.24 M | -71.32% | 0.26% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 284,850 | $2.22 M | -16.79% | 0.26% |
HIGHVISTA STRATEGIES LLC | 02/14/2025 | 279,673 | $2.18 M | 23.95% | 0.25% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 277,523 | $2.16 M | 184.45% | 0.25% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 275,292 | $2.15 M | 60.05% | 0.25% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 258,766 | $2.02 M | -1.83% | 0.23% |
NEW LEAF VENTURE PARTNERS, L.L.C. | 02/13/2025 | 250,765 | $1.96 M | 0.00% | 0.23% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 242,929 | $1.89 M | 100.00% | 0.22% |
MACQUARIE GROUP LTD | 02/14/2025 | 230,000 | $1.79 M | 0.00% | 0.21% |
UBS GROUP AG | 02/14/2025 | 213,934 | $1.67 M | 85.23% | 0.19% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 202,500 | $1.58 M | 100.00% | 0.18% |
BARCLAYS PLC | 02/13/2025 | 193,068 | $1.51 M | 9.90% | 0.18% |
Cogent Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 198 institutional investors and hedge funds held shares of Cogent Biosciences, Inc.. The most heavily invested institutionals were:
FMR LLC: 16.57 M
Kynam Capital Management, LP: 9.11 M
BlackRock Funding, Inc. /DE: 8.34 M
TCG Crossover Management, LLC: 6.96 M
COMMODORE CAPITAL LP: 6.88 M
Fairmount Funds Management LLC: 6.23 M
110.48% of Cogent Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 128.89 M shares in the last 24 months. This purchase volume represents approximately $1.04 B in transactions.